VistaGen Global Leader in Stem Cell Technologies for Pharmaceutical Development Identification of Surrogate Markers for Predicting Drug Responses Advisory.

Slides:



Advertisements
Similar presentations
Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
Advertisements

The Role of Drug Metabolism Studies in Optimizing Drug Candidates
The Expression of NPPA Splice Variants During Cardiac Differentiation of Mouse Mesenchymal and Embryonic Stem Cells Masoumeh Fakhr Taha PhD, Arash Javeri.
Characterization of Transcriptional Regulatory Networks controlling plant cell adaptation to environmental stresses.
Stem Cells: Roadmap to the clinic Negar Azarpira, MD Associate professor of Pathology 14 April 2010.
Biology 129 Human Biology Richard R. Almon Ph.D Professor Departments of Biological Sciences, Pharmaceutical Sciences and The NY State Center of Excellence.
Announcements ● Tutoring Center SCI I, 407 M 12-3, 5:30-6:30; W 8-9, 5:30-6:30, Th 8-12, 6-7; F 8-9 ● MasteringBiology Assignment due Tuesday 5/24 ● Today’s.
Applications of protomic Presented By: Muhammad Rizwan Roll no: Department of Bioinformatics.
Scope and Application of Stem Cell Research in Livestock Jayanti Tokas 1, Puneet Tokas 2, Shailini Jain 3, Hariom Yadav 3 1 Department of Biotechnology,
 The direct manipulation of an organisms genome using biotechnology  New DNA is inserted into a host genome  Host organism transcribes and translates.
Stem Cell Notes IB Biology HL 1 Mrs. Peters Winter 2014.
Stem cells and gene therapy to repair the damaged heart: will it work and is it right? John Martin Professor of Cardiovascular Medicine University College.
Integrating Scientific Advances into Regulation: Pharmacogenomics and Pharmacogenetics Janet Woodcock, M.D. Director, Center for Drug Evaluation and Research.
Knowledgebase Creation & Systems Biology: A new prospect in discovery informatics S.Shriram, Siri Technologies (Cytogenomics), Bangalore S.Shriram, Siri.
CELL TECHNOLOGY Stem Cells Definition
Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.
Health Biotechnology Stem Cell Therapeutics; Tissue Engineering LECTURE 21: Biotechnology; 3 Credit hours Atta-ur-Rahman School of Applied Biosciences.
The Need for Organ Site Specific Cancer Research John T Isaacs Chemical Therapeutic Program Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
CS 790 – Bioinformatics Introduction and overview.
FINDING THE DISEASE GENES PROGRESS AND PROBLEMS THE HUMAN GENOME MAPPING PROJECT SEEKS TO READ THE FULL SEQUENCE OF THE HUMAN GENOME 3 Billion bases.
Learning Targets I can describe cell specialization and levels of organization. I can identify how levels of organization work together in an organism.
Copyright © 2009 Pearson Education, Inc. Art and Photos in PowerPoint ® Concepts of Genetics Ninth Edition Klug, Cummings, Spencer, Palladino Chapter 21.
1 Cancer in Children Chapter 13. Mosby items and derived items © 2006 by Mosby, Inc. 2 Childhood Cancers  Most originate from the mesodermal germ layer.
Cell Specialization Remember..... All living things are made of cells!!! Cells can specialize into different cell types Cells  tissues  organs These.
BIOMARKERS Diagnostics and Prognostics. OMICS Molecular Diagnostics: Promises and Possibilities, p. 12 and 26.
KEY CONCEPT The human body has five levels of organization.
Ahsan Arsalan Stem Cells Present in almost all multi-cellular organisms No specialized functionality Can renew themselves Can differentiate into.
Stem Cells Science in the News Adapted by your teacher Ms. Boehm.
Organization of Life. Levels of Organization The different branches of biology can be classified based on different levels of complexity Each “level”
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Cell Differentiation – Stem Cells how specialized cells get produced controlled by the cell’s DNA stem cells are animal cells that can differentiate into.
Copyright © 2009 Pearson Education, Inc. Genomics, Bioinformatics, and Proteomics Chapter 21 Lecture Concepts of Genetics Tenth Edition.
Advances in Stem Cell Therapy Karim Nayernia Professor of Human Genetics & Stem Cell Biology.
Bioinformatics MEDC601 Lecture by Brad Windle Ph# Office: Massey Cancer Center, Goodwin Labs Room 319 Web site for lecture:
Stem Cells Science and Society.
Jasna Marinović, M.D., Ph.D. Associate Professor Department of Physiology.
Dr. Abdullah Aldahmash. Cell Stem Cell – Definition A cell which has the ability to continuously divide and differentiate into various other kinds of.
IB Biology HL 1 Mrs. Peters Fall Organization of Living Things Cells: either unicellular or multicellular Tissues: only in multicellular organisms,
Identification of co-expression networks by comparison of a multitude of different functional states of genome activity Marc Bonin 1, Stephan Flemming.
Stem cells through the lens of the Korean cloning scandal.
Tissue lab power point. Simple squamous- it’s 1 layer and flat…so getting a great slide is difficult!
Some common genetic engineering applications A brief overview.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
Biotechnology: using living systems to improve human life.
Shows tendency for mergers. These big companies may be shrinking – much research is now outsourced to low cost countries like Latvia, India, China and.
Ch.20 Biotechnology. Overview: The DNA Toolbox History  1970’s Recombinant DNA  2001 Human Genome Project  10 years, $3 billion  Genomes.
Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
SciLifeLab DDD Platform – built for function
Cell Specialization and Differentiation
Conceptual approach for incorporating “omics” technologies and resulting large databases into toxicological evaluation. Data from experiments that evaluate.
Stem Cell Research
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
An Introduction to Medicinal Chemistry 3/e
Hmdscience.com username: cpiro23 password: x2p4n
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Cell Differentiation.
Observable cell differentiation results from the expression of genes for tissue-specific proteins. Re-write the sentence above in your own words.
PREDICT.
Stem Cells and Drug Discovery: The Beginning of a New Era?
The student is expected to: 10C analyze the levels of organization in biological systems and relate the levels to each other and to the whole system.
Rational for the 5R Philosophy
KEY CONCEPT The human body has five levels of organization.
Diagnostics and Prognostics
Jin Zhang, Hu Li, Alan Trounson, Joseph C. Wu, Paul Nioi 
Plant and Animal Biotechnology
Expanding Reprogramming to Cardiovascular Progenitors
The Systematic Production of Cells for Cell Therapies
RSESS March 18, 2008 Robert Osterberg
Presentation transcript:

VistaGen Global Leader in Stem Cell Technologies for Pharmaceutical Development Identification of Surrogate Markers for Predicting Drug Responses Advisory Committee for Pharmaceutical Science March 9, 2000

VistaGen © 2000 Approach to Identifying Surrogate Markers for Drug Responses  Biology platform based on embryonic stem cell systems – complex, interactive, multi-tissue therapeutic index  High through-put drug prioritization based on an in vitro “therapeutic index” KnowledgeBase  Retrospective KnowledgeBase of successful and failed drugs  Better understanding of species differences for predicting MTD for clinical testing  Model system for evaluating genetic polymorphisms & drug responses

VistaGen © 2000 Genesis Screen™: Complex Biology

VistaGen © 2000 Genesis Screen™: Complex Biology  Complex tissue development  Suitable for screening –blood –muscle –endothelial (blood vessels) –neuronal –connective tissues –other

VistaGen © 2000 ES Cells & Drug Testing Tissues ES Cell Differentiation Differentiation Comparative Bioinformatics MuscleCells Drug Leads Protein & Gene Expression Profiles Protein & Gene Expression Profiles Predictive Efficacy & Toxicity Predictive BoneCells BloodCellsBloodVesselsNeuronalDevelopment

VistaGen © 2000 Predictive Toxicity = Pattern Matching Putting History to Work for Us Internal Reference Standards Reference StandardsUnknown Test Compound “Clinical”Effect liver tox cardiac tox kidney tox neuronal tox Cyp 1A1 inhibitor liver tox2

VistaGen Ralph Snodgrass, CEO VistaGen, Inc. Mountain View, CA

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.